The role of lithium in modulation of brain genes: Relevance for aetiology and treatment of bipolar disorder

Biochemical Society Transactions

Volumn 37, Issue 5, 2009, Pages 1090-1095

  Fatemi, S Hossein ^a   Reutiman, Teri J ^a   Folsom, Timothy D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Catechol O methyltransferase (COMT); DNA microarray; Frontal cortex; Lithium; Vesicle associated membrane protein associated protein A (VAPA)

Indexed keywords

CATECHOL METHYLTRANSFERASE; DYSTROBREVIN; LITHIUM SALT; SYNAPTOBREVIN;

APOPTOSIS; BIPOLAR DISORDER; CONFERENCE PAPER; DOWN REGULATION; DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; SYNAPTIC TRANSMISSION; UPREGULATION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BRAIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LITHIUM COMPOUNDS; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

RATTUS;

EID: 70350161415     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371090     Document Type: Conference Paper

References (60)

1. Clayton, P.J. (2008) Bipolar illness. in The Medical Basis of Psychiatry, 3rd Edn (Fatemi, S.H. and Clayton, P.J., eds), pp. 47-71, Humana Press, New York
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn., American Psychiatric Publishing, Washington, DC
3. Calabrese, J.R. (2008) Overview of patient care issues and treatment in bipolar spectrum and bipolar II disorder. J. Clin. Psychiatry 69, e18
4. Youngs, R.M., Chu, M.S., Meloni, E.G., Naydenov, A., Carlezon, Jr, W.A. and Konradi, C. (2006) Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences. J. Neurosci. 26, 6031-6039
5. McQuillin, A., Rizig, M. and Gurling, H.M. (2007) A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet. Genomics 17, 605-617
6. Chetcuti, A., Adams, L.J., Mitchell, P.B. and Schofield, P.R. (2008) Microarray gene expression profiling of mouse brain mRNA in a model of lithium treatment. Psychiatr. Genet. 18, 64-72
7. Männistö, P.T. and Kaakkola, S. (1999) Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol. Rev. 51, 593-628
8. Gogos, J.A., Morgan, M., Luine, V., Santha, M., Ogawa, S., Pfaff, D. and Karayiorgou, M. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U.S.A. 95, 9991-9996
9. Karoum, F., Chrapusta, S.J. and Egan, M.F. (1994) 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J. Neurochem. 63, 972-979
10. Tunbridge, E.M., Bannerman, D.M., Sharp, T. and Harrison, P.J. (2004) Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex. J. Neurosci. 24, 5331-5335
11. Goghari, V.M. and Sponheim, S.R. (2008) Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophr. Res. 103, 186-191
12. Dickerson, F., Stallings, C., Sullens, A., Origoni, A., Leister, F., Krivogorsky, B. and Yolken, R. (2008) Association between cognitive functioning, exposure to herpes simplex virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder. Brain Behav. Immun. 22, 1103-1107
13. Burdick, K.E., Funke, B., Goldberg, J.F., Bates, J.A., Jaeger, J., Kucherlapati, R. and Malhotra, A.K. (2007) COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord. 9, 370-376
14. Prata, D.P., Breen, G., Munro, J., Sinclair, M., Osborne, S., Li, T., Kerwin, R., St. Clair, D. and Collier, D.A. (2006) Bipolar 1 disorder is not associated with the RGS4, PRODH, COMT and GRK3 genes. Psychiatr. Genet. 16, 229-230
15. Serretti, A., Rotondo, A., Lorenzi, C., Smeraldi, E. and Cassano, G.B. (2006) Catechol-O-methyltransferase gene variants in mood disorders in the Italian population. Psychiatr. Genet. 16, 181-182
16. Fatemi, S.H. and Folsom, T.D. (2007) Catechol-O-methyltransferase gene regulation in rat frontal cortex. Mol. Psychiatry 12, 322-323
17. Weir, M.L., Klip, A. and Trimble, W.S. (1998) Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP. Biochem. J. 333, 247-251
18. Weir, M.L., Xie, H., Klip, A. and Trimble, W.S. (2001) VAP-A binds promiscuously to both v- and tSNAREs. Biochem. Biophys. Res. Commun. 286, 616-621
19. Skehel, P.A., Martin, K.C., Kandel, E.R. and Bartsch, D. (1995) A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269, 1580-1583
20. Lohoff, F.W., Weller, A.E., Bloch, P.J., Nall, A.H., Ferraro, T.N. and Berrettini, W.H. (2008) Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder. J. Neural Transm. 115, 1339-1345
21. Honer, W.G., Falkai, P., Bayer, T.A., Xie, J., Hu, L., Li, H.-Y., Arango, V., Mann, J.J., Dwork, A.J. and Trimble, W.S. (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb. Cortex 12, 349-356
22. Beasley, C.L., Honer, W.G., Bergmann, K., Falkai, P., Lutjohann, D. and Bayer, T.A. (2005) Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord. 7, 449-455
23. Prosser, D.C., Tran, D., Gougeon, P.Y., Verly, C. and Ngsee, J.K. (2008) FFAT rescues VAPA-mediated inhibition of ER-to-Golgi transport and VAPB-mediated ER aggregation. J. Cell Sci. 121, 3052-3061
24. Chagnon, Y.C., Roy, M.A., Bureau, A., Mérette, C. and Maziade, M. (2008) Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. Schizophr. Res. 100, 281-290
25. Gaysina, D., Cohen-Woods, S., Chow, P.C., Martucci, L., Schosser, A., Ball, H.A., Tozzi, F., Perry, J., Muglia, P., Craig, I.W. et al. (2009) Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS). Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 836-844
26. Talbot, K., Eidem, W.L., Tinsley, C.L., Benson, M.A., Thompson, E.W., Smith, R.J., Hahn, C.G., Siegel, S.J., Trojanowski, J.Q., Gur, R.E. et al. (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113, 1353-1363
27. Daniels, R.J., Peden, J.F., Lloyd, C., Horsley, S.W., Clark, K., Tufarelli, C., Kearney, L., Buckle, V.J., Doggett, N.A., Flint, J. and Higgs, D.R. (2001) Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum. Mol. Genet. 10, 339-352
28. Stokely, M.E., Hwang, S.Y., Hwang, J.Y., Fan, B., King, M.A., Inokuchi, K. and Koulen, P. (2006) Polycystin-1 can interact with homer 1/Vesl-1 in postnatal hippocampal neurons. J. Neurosci. Res. 84, 1727-1737
29. Tokumaru, H., Umayahara, K., Pellegrini, L.L., Ishizuka, T., Saisu, H., Betz, H., Augustine, G.J. and Abe, T. (2001) SNARE complex oligomerization by synaphin/complexin is essential for synaptic vesicle exocytosis. Cell 104, 421-432
30. 2+-dependent neurotransmitter release. Cell 104, 71-81
31. Glynn, D., Bortnick, R.A. and Morton, A.J. (2003) Complexin II is essential for normal neurological function in mice. Hum. Mol. Genet. 12, 2431-2448
32. Ravasi, T., Hsu, K., Goyette, J., Schroder, K., Yang, Z., Rahimi, F., Miranda, L.P., Alewood, P.F., Hume, D.A. and Geczy, C. (2004) Probing the S100 protein family through genomic and functional analysis. Genomics 84, 10-22
33. Heizmann, C.W., Fritz, G. and Schafer, B.W. (2002) S100 proteins: structure, functions and pathology frontiers. Bioscience 7, d1356-d1368
34. Cecil, D.L. and Terkeltaub, R. (2008) Transamidation by transglutaminase 2 transforms S100A11 calgranulin into a procatabolic cytokine for chondrocytes. J. Immunol. 180, 8378-8385
35. Cross, S.S., Hamdy, F.C., Deloulme, J.C. and Rehman, I. (2005) Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 46, 256-269
36. Fatemi, S.H., Reutiman, T.J. and Folsom, T.D. (2006) Olanzapine upregulates genes for S100A8 and S100A9 in frontal cortex of rats. Neuropsychopharmacology 31, 2568-2569
37. Svenningsson, P., Cherugi, K., Rachleff, I., Flajolet, M., Zhang, X., Yacoubi, M.E., Vargeois, J.M., Nomikos, G.G. and Greengard, P. (2006) Alterations in 5HT1β receptor function by p11 in depression-like states. Science 311, 77-80
38. Wang, X.M., Yu, D.M., McCaughan, G.W. and Gorrell, M.D. (2005) Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology 42, 935-945
39. Glasgow, J.N., Qiu, J., Rassin, D., Grafe, M., Wood, T. and Perez-Pol, J.R. (2001) Transcriptional regulation of the BCL-X gene by NF-κB is an element of hypoxic responses in the rat brain. Neurochem. Res. 26, 647-659
40. Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T., Turka, L.A., Mao, X., Nunez, G. and Thompson, C.B. (1993) Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608
41. L and inhibiting mitochondrial Bax translocation. Neurobiol. Dis. 8, 764-773
42. Manji, H.K., Moore, G.J. and Chen, M.D. (2000) Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J. Clin. Psychiatry 61, 82-96
43. Marmol, F. (2008) Lithium: bipolar disorder and neurodegenerative diseases. Possible cellular mechanisms of the therapeutic effects of lithium. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1761-1771
44. Dutheil, F., Dauchy, S., Diry, M., Sazdovitch, V., Cloarec, O., Mellottee, L., Bieche, I., Ingelman-Sundberg, M., Flinois, J.P., de Waziers, I. et al. (2009) Xenobiotic metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab. Dispos. 37, 1528-1538
45. Mikawa, S., Wang, C. and Sato, K. (2006) Bone morphogenetic protein-4 expression in the adult rat brain. J. Comp. Neurol. 499, 613-625
46. McGrath, J.L. (2005) Dynein motility: four heads are better than two. Curr. Biol. 15, R970-R972
47. McHugh, P., Rogers, G., Glubb, D., Joyce, P. and Kennedy, M. (2009) Proteomic analysis of rat hippocampus exposed to the antidepressant paroxetine. J. Psychopharmacol., doi:10.1177/0269881109102786
48. Driskell, O.J., Mironov, A., Allan, V.J. and Woodman, P.G. (2007) Dynein is required for receptor sorting and the morphogenesis of early endosomes. Nat. Cell Biol. 9, 113-120
49. Spencer, C.M., Jahng, J.W., Ryu, V. and Houpt, T.A. (2005) Lithium-induced gene expression of inducible cyclic adenosine monophosphate early repressor in the rat adrenal gland. J. Neurosci. Res. 82, 273-282
50. Asghari, V., Wang, J.F., Reiach, J.S. and Young, L.T. (1998) Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Mol. Brain Res. 58, 95-102
51. Karin, M. and Hunter, T. (1995) Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus. Curr. Biol. 5, 747-757
52. Laifenfeld, D., Karry, R., Grauer, E., Klein, E. and Ben-Shachar, D. (2004) ATF2, a member of the CREB/ATF family of transcription factors, in chronic stress and consequent to antidepressant treatment: animal models and human post-mortem brains. Neuropsychopharmacology 29, 589-597
53. Marui, T., Funatogawa, I., Koishi, S., Yamamoto, K., Matsumoto, H., Hashimoto, O., Nanba, E., Nishida, H., Sugiyama, T., Kasai, K. et al. (2007) Tachykinin 1 (TAC1) gene SNPs and haplotypes with autism: a case-control study. Brain Dev. 29, 510-513
54. Bilkei-Gorzo, A., Racz, I., Michel, K. and Zimmer, A. (2002) Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J. Neurosci. 22, 10046-10052
55. Ogden, C.A., Rich, M.E., Schork, N.J., Paulus, M.P., Geyer, M.A., Lohr, J.B., Kuczenski, R. and Niculescu, A.B. (2004) Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol. Psychiatry 9, 1007-1029
56. Hahn, M.K., Blackford, J.U., Haman, K., Mazei-Robison, M., English, B.A., Prasad, H.C., Steele, A., Hazelwood, L., Fentress, H.M., Myers, R. et al. (2008) Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression. Genes Brain Behav. 7, 487-495
57. Berk, M., Dodd, S., Kauer-Sant'anna, M., Malhi, G.S., Bourin, M., Kapczinski, F. and Norman, T. (2007) Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr. Scand. Suppl. 434, 41-49
58. 1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry 42, 20-22
59. Verma, R., Kubendran, S., Das, S.K., Jain, S. and Brahmachari, S.K. (2005) SYNGR1 is associated with schizophrenia and bipolar disorder in southern India. J. Hum. Genet. 50, 635-640
60. Lachman, H.M., Stopkova, P., Papolos, D.F., Pedrosa, E., Margolis, B., Aghalar, M.R. and Saito, T. (2006) Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder. Neuropsychobiology 53, 57-62